(19)

(11)

EP 4 334 941 A1

(12)

(43) Date of publication: 13.03.2024 Bulletin 2024/11 (21) Application number: 22738177.9 (22) Date of filing: 10.06.2022

(51) International Patent Classification (IPC):  G16B 5/00(2019.01) G16H 30/40(2018.01) G16H 20/10(2018.01) (52) Cooperative Patent Classification (CPC): G16B 5/00; G16H 20/10; G16H 30/40; G16B 20/00 (86) International application number: PCT/US2022/033115 (87) International publication number: WO 2022/261506 (15.12.2022 Gazette 2022/50)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 10.06.2021 US 202163209164 P 11.03.2022 US 202217693229 (71) Applicant: Elucid Bioimaging Inc. Boston, MA 02116 (US)	(72) Inventors: BUCKLER, Andrew J. Boston, Massachusetts 02116 (US) HEDIN, Ulf Boston, Massachusetts 02116 (US) MATIC, Ljubica Boston, Massachusetts 02116 (US) PHILLIPS, Matthew Boston, Massachusetts 02116 (US) (74) Representative: Fish & Richardson P.C.  Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München 80807 München (DE)